Moreover, adiponectin seems toact in a protective way in comorbidities such as diabetes mellitus type 2, insulinresistance, metabolic syndrome, and inflammation [21]–[23], whereas correlations ofleptin to classical risk markers such as troponin-I and C-reactive protein mayreflect the degree of inflammation in the process of plaque instability [24]. Here, ADIPOQ is linked to diabetes mellitus.